Team:Imperial College London/Achievements

From 2010.igem.org

(Difference between revisions)
m
Line 13: Line 13:
  <img style="width:30px;" src="https://static.igem.org/mediawiki/2010/5/56/ICtickicon.png" />
  <img style="width:30px;" src="https://static.igem.org/mediawiki/2010/5/56/ICtickicon.png" />
</html>
</html>
-
|Run a series of Synthetic Biology School Workshops, and have provided tools for others to follow suit.
+
|Ran a series of Synthetic Biology School Workshops, and provided tools for others to follow suit.
|-
|-
|align="center"|<html>
|align="center"|<html>
  <img style="width:30px;" src="https://static.igem.org/mediawiki/2010/5/56/ICtickicon.png" />
  <img style="width:30px;" src="https://static.igem.org/mediawiki/2010/5/56/ICtickicon.png" />
</html>
</html>
-
|Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation (PyrD and AmyE vectors and Dif excision of antibiotic resistance genes).
+
|Outlined and detailed a new approach to an issue of Human Practice in synthetic biology as it relates to our project, such as safety, security, ethics, or ownership, sharing, and innovation (PyrD and AmyE vectors and Dif excision of antibiotic resistance genes).
|-
|-
|align="center"|<html>
|align="center"|<html>

Revision as of 10:37, 27 October 2010

Achievements
We have:
Had a fantastic summer, learnt loads and formed new friendships.
Ran a series of Synthetic Biology School Workshops, and provided tools for others to follow suit.
Outlined and detailed a new approach to an issue of Human Practice in synthetic biology as it relates to our project, such as safety, security, ethics, or ownership, sharing, and innovation (PyrD and AmyE vectors and Dif excision of antibiotic resistance genes).
Tackled the problem of Neglected Tropical Diseases for the first time in the iGEM competition.
Characterized XylE.
Designed a software tool for protease detection and protein presentation on the surface of B. subtilis.
Submitted a fantastic natural BioBrick Part, the LytC CWBD.
Submitted two great novel engineered BioBrick parts; GFP-XylE and the enhanced LacI promoter.
Characterized the operation of the new BioBrick part GFP-XylE.
Based our specifications on modelling and human practices.
Characterised modules in both B. subtilis and E. Coli.
Managed to get loads of experimental measurements!
Helped three iGEM teams (Warsaw, UNAM-Mexico and METU-Turkey) by completing their surveys.